Focusing on DIY Fitness Crowd Is a Good Start, Says Analyst
On the heels of a solid fiscal first quarter beat from Alibaba Group Holding Ltd (NYSE:BABA), analyst Jason Helfstein of Oppenheimer is becoming …
Oppenheimer analyst Jay Olson is out with a bullish research note on TherapeuticsMD Inc (NYSEMKT:TXMD), after a positive independent observational study conducted by the …
After releasing disappointing fiscal fourth quarter earnings yesterday, Cisco Systems, Inc. (NASDAQ:CSCO) shareholders got the jitters, sending the stock plunging around 4% this …
Urban Outfitters, Inc. (NASDAQ:URBN) stock shot up yesterday by 23% after the company shook off a string of 8 disappointing quarters with impressive …
Analyst Brian Bittner of Oppenheimer posted a bullish note on Jack in the Box Inc. (NASDAQ:JACK) following fiscal third quarter results that fared …
Upon releasing negative data for lead drug candidate transdermal CBD (ZYN002) on Monday, Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) investors ran for the hills, sending …
As the peak of earnings season continues, Oppenheimer analysts are weighing in on tech giant Apple Inc.(NASDAQ:AAPL) and athletic apparel giant Under Armour Inc …
In a research report released Monday, Oppenheimer analyst Derek Archila reiterated a Perform rating on shares of Endo International plc (NASDAQ:ENDP), while estimating fair …
Oppenheimer analyst Derek Archila sees some short-term capital rocky waters for Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and awaits more details post-Trulance launch, but continues to …
